Last updated March 15, 2022

Follow-Up And Surveillance Of The Patient With Lung Cancer After Curative-Intent Therapy: Diagnosis And Management Of Lung Cancer

Recommendations

The Role of Imaging Studies

In patients who have undergone curative-intent surgical resection of NSCLC, it is suggested that chest CT be performed every 6 months for the first 2 years after resection and every year thereafter. (2, C)
307795
For patients with NSCLC or carcinoid tumor who have undergone curative-intent therapy, it is recommended that the original treating physicians participate in the decision-making process during the follow-up and surveillance. (1, C)
307795
After curative-intent therapy in patients with NSCLC or carcinoid tumors, routine surveillance with PET imaging, somatostatin receptor scintigraphy (SRS) or abdominal ultrasonography is not recommended. (1, C)
307795

The Role of HRQOL

In NSCLC patients who have undergone curative-intent therapy, it is suggested that a validated HRQOL instrument be used at baseline clinic visits and during follow-up. (2, C)
307795

The Role of Tumor Markers

For lung cancer patients treated with curative intent, it is suggested that surveillance biomarker testing not be done (outside of clinical trials). (2, C)
307795

The Role of Bronchoscopy

For patients with early central airway SqCC treated by curative-intent PDT, it is recommended that surveillance bronchoscopy be done at 1, 2, and 3 months, and thereafter at 3-month intervals during the first year, then every 6 months until 5 years. (1, C)
307795
For patients with intraluminal bronchial carcinoid tumor who have undergone curative-intent bronchoscopic treatment using Nd:YAG or electrocautery, it is suggested that surveillance bronchoscopy be done within 6 weeks after endobronchial resection, every 6 months for 2 years, and annually thereafter. (2, C)
307795

Recommendation Grading

Overview

Title

Follow-Up And Surveillance Of The Patient With Lung Cancer After Curative-Intent Therapy: Diagnosis And Management Of Lung Cancer

Authoring Organization

Publication Month/Year

May 1, 2013

Document Type

Guideline

External Publication Status

Published

Country of Publication

US

Document Objectives

These guidelines are an update of the evidence-based recommendations for follow-up and surveillance of patients after curative-intent therapy for lung cancer. Particular updates pertain to whether imaging studies, health-related quality-of-life (HRQOL) measures, tumor markers, and bronchoscopy improve outcomes after curative-intent therapy.

Target Patient Population

Patients underwent curative intent therapy for lung cancer

Inclusion Criteria

Female, Male, Adolescent, Adult, Older adult

Health Care Settings

Ambulatory, Hospital, Operating and recovery room, Outpatient, Radiology services

Intended Users

Nurse, nurse practitioner, physician, physician assistant

Scope

Counseling, Assessment and screening, Management

Diseases/Conditions (MeSH)

D018787 - Radiation Oncology, D008175 - Lung Neoplasms, D000073116 - Cancer Survivors, D005500 - Follow-Up Studies, D013902 - Radiography, Thoracic

Keywords

surveillance, lung cancer, follow-up, cancer survivors, counseling